Clinical relevance of vascular endothelial growth factor (VEGFA) and VEGF receptor (VEGFR2) gene polymorphism on the treatment outcome following imatinib therapy.
(41/311)
(+info)
Outcome following resection for patients with primary mediastinal nonseminomatous germ-cell tumors and rising serum tumor markers post-chemotherapy.
(42/311)
(+info)
Selegiline and oxidative stress in HIV-associated cognitive impairment.
(43/311)
(+info)
In vivo pharmaco-proteomic analysis of hydroxyurea induced changes in the sickle red blood cell membrane proteome.
(44/311)
(+info)
Warfarin sensitivity genotyping: a review of the literature and summary of patient experience.
(45/311)
(+info)
Elimination kinetics of the tobacco-specific biomarker and lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol.
(46/311)
(+info)
Utility and relationships of biomarkers of smoking in African-American light smokers.
(47/311)
(+info)
Selective recruitment of breast cancer anti-estrogen resistance genes and relevance for breast cancer progression and tamoxifen therapy response.
(48/311)
(+info)